Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorTCHOUKAEV, Anastasia
dc.contributor.authorTAYTARD, Jessica
dc.contributor.authorROUSSELET, Nathalie
dc.contributor.authorREBEYROL, Carine
dc.contributor.authorDEBRAY, Dominique
dc.contributor.authorBLOUQUIT-LAYE, Sabine
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorMOISAN, Marie Pierre
IDREF: 060242264
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorFOURY, Aline
dc.contributor.authorGUILLOT, Loic
dc.contributor.authorCORVOL, Harriet
dc.contributor.authorTABARY, Olivier
dc.contributor.authorLE ROUZIC, Philippe
dc.date.accessioned2021-09-28T10:03:04Z
dc.date.available2021-09-28T10:03:04Z
dc.date.issued2018
dc.identifier.issn1663-9812en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/112462
dc.description.abstractEnCystic fibrosis (CF) is characterized by a chronic pulmonary inflammation. In CF, glucocorticoids (GC) are widely used, but their efficacy and benefit/risk ratio are still debated. In plasma, corticosteroid-binding globulin (CBG) binds 90% of GC and delivers them to the inflammatory site. The main goal of this work was to study CBG expression in CF patients in order to determine whether CBG could be used to optimize GC treatment. The expression of CBG was measured in liver samples from CF cirrhotic and non-CF cirrhotic patients by qPCR and Western blot and in lung samples from non-CF and CF patients by qPCR. CBG binding assays with H-3-cortisol and the measurement of the elastase/alpha 1-antitrypsin complex were performed using the plasmas. CBG expression increased in the liver at the transcript and protein level but not in the plasma of CF patients. This is possibly due to an increase of plasmatic elastase. We demonstrated that pulmonary CBG was expressed in the bronchi and bronchioles and its expression decreased in the CF lungs, at both levels studied. Despite the opposite expression of hepatic and pulmonary CBG in CF patients, the concentration of CBG in the plasma was normal. Thus, CBG might be useful to deliver an optimized synthetic GC displaying high affinity for CBG to the main inflammatory site in the context of CF, e.g., the lung.
dc.language.isoENen_US
dc.rightsAttribution 4.0 International (CC BY 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.enCorticosteroid-binding globulin
dc.subject.enCystic fibrosis
dc.subject.enGlucocorticoids
dc.subject.enLiver
dc.subject.enLung
dc.title.enOpposite expression of hepatic and pulmonary corticosteroid-binding globulin in cystic fibrosis patients
dc.typeArticle de revueen_US
dc.identifier.doi10.3389/fphar.2018.00545en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed29922157en_US
bordeaux.journalFrontiers in Pharmacologyen_US
bordeaux.page1-9en_US
bordeaux.volume9en_US
bordeaux.hal.laboratoriesNutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.teamNutrition, mémoire et glucocorticoïdesen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDInstitut National de la Santé et de la Recherche Médicaleen_US
bordeaux.identifier.funderIDUniversité Pierre et Marie Curieen_US
bordeaux.identifier.funderIDAssociation Vaincre la Mucoviscidoseen_US
bordeaux.identifier.funderIDMinistère de l’Enseignement Supérieur et de la Recherche Scientifiqueen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers%20in%20Pharmacology&rft.date=2018&rft.volume=9&rft.spage=1-9&rft.epage=1-9&rft.eissn=1663-9812&rft.issn=1663-9812&rft.au=TCHOUKAEV,%20Anastasia&TAYTARD,%20Jessica&ROUSSELET,%20Nathalie&REBEYROL,%20Carine&DEBRAY,%20Dominique&rft.genre=article


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée